Literature DB >> 25344549

Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction.

Bishnu P Dhakal1, Rajeev Malhotra1, Ryan M Murphy1, Paul P Pappagianopoulos1, Aaron L Baggish1, Rory B Weiner1, Nicholas E Houstis1, Aaron S Eisman1, Stacyann S Hough1, Gregory D Lewis2.   

Abstract

BACKGROUND: Exercise capacity as measured by peak oxygen uptake (Vo2) is similarly impaired in patients with heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF). However, characterization of how each component of Vo2 changes in response to incremental exercise in HFpEF versus HFrEF has not been previously defined. We hypothesized that abnormally low peripheral o2 extraction (arterio-mixed venous o2 content difference, [C(a-v)o2]) during exercise significantly contributes to impaired exercise capacity in HFpEF. METHODS AND
RESULTS: We performed maximum incremental cardiopulmonary exercise testing with invasive hemodynamic monitoring on 104 patients with symptomatic NYHA II to IV heart failure (HFpEF, n=48, peak Vo2=13.9±0.5 mL kg(-1) min(-1), mean±SEM, and HFrEF, n=56, peak Vo2=12.1±0.5 mL kg(-1) min(-1)) and 24 control subjects (peak Vo2 27.0±1.7 mL kg(-1) min(-1)). Peak exercise C(a-v)o2 was lower in HFpEF compared with HFrEF (11.5±0.27 versus 13.5±0.34 mL/dL, respectively, P<0.0001), despite no differences in age, hemoglobin level, peak respiratory exchange ratio, Cao2, or cardiac filling pressures. Peak C(a-v)o2 and peak heart rate emerged as the leading predictors of peak Vo2 in HFpEF. Impaired peripheral o2 extraction was the predominant limiting factor to exercise capacity in 40% of patients with HFpEF and was closely related to elevated systemic blood pressure during exercise (r=0.49, P=0.0005).
CONCLUSIONS: In the first study to directly measure C(a-v)o2 throughout exercise in HFpEF, HFrEF, and normals, we found that peak C(a-v)o2 was a major determinant of exercise capacity in HFpEF. The important functional limitation imposed by impaired o2 extraction may reflect intrinsic abnormalities in skeletal muscle or peripheral microvascular function, and represents a potential target for therapeutic intervention.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  diastole; exercise; heart failure

Mesh:

Year:  2014        PMID: 25344549      PMCID: PMC5771713          DOI: 10.1161/CIRCHEARTFAILURE.114.001825

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  59 in total

1.  The number and distribution of capillaries in muscles with calculations of the oxygen pressure head necessary for supplying the tissue.

Authors:  A Krogh
Journal:  J Physiol       Date:  1919-05-20       Impact factor: 5.182

2.  Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure.

Authors:  Gregory D Lewis; Justine Lachmann; Janice Camuso; John J Lepore; Jordan Shin; Maryann E Martinovic; David M Systrom; Kenneth D Bloch; Marc J Semigran
Journal:  Circulation       Date:  2006-12-18       Impact factor: 29.690

3.  Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction.

Authors:  Mark J Haykowsky; Peter H Brubaker; Jerry M John; Kathryn P Stewart; Timothy M Morgan; Dalane W Kitzman
Journal:  J Am Coll Cardiol       Date:  2011-07-12       Impact factor: 24.094

4.  Limited maximal exercise capacity in patients with chronic heart failure: partitioning the contributors.

Authors:  Fabio Esposito; Odile Mathieu-Costello; Ralph Shabetai; Peter D Wagner; Russell S Richardson
Journal:  J Am Coll Cardiol       Date:  2010-05-04       Impact factor: 24.094

5.  Non-invasive measurement of stroke volume during exercise in heart failure patients.

Authors:  P G Agostoni; K Wasserman; G B Perego; M Guazzi; G Cattadori; P Palermo; G Lauri; G Marenzi
Journal:  Clin Sci (Lond)       Date:  2000-05       Impact factor: 6.124

Review 6.  Determinants of maximal oxygen transport and utilization.

Authors:  P D Wagner
Journal:  Annu Rev Physiol       Date:  1996       Impact factor: 19.318

7.  Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations.

Authors:  Miho Kawaguchi; Ilan Hay; Barry Fetics; David A Kass
Journal:  Circulation       Date:  2003-02-11       Impact factor: 29.690

8.  Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.

Authors:  Margaret M Redfield; Horng H Chen; Barry A Borlaug; Marc J Semigran; Kerry L Lee; Gregory Lewis; Martin M LeWinter; Jean L Rouleau; David A Bull; Douglas L Mann; Anita Deswal; Lynne W Stevenson; Michael M Givertz; Elizabeth O Ofili; Christopher M O'Connor; G Michael Felker; Steven R Goldsmith; Bradley A Bart; Steven E McNulty; Jenny C Ibarra; Grace Lin; Jae K Oh; Manesh R Patel; Raymond J Kim; Russell P Tracy; Eric J Velazquez; Kevin J Anstrom; Adrian F Hernandez; Alice M Mascette; Eugene Braunwald
Journal:  JAMA       Date:  2013-03-27       Impact factor: 56.272

Review 9.  Exercise testing for chronotropic assessment.

Authors:  B L Wilkoff; R E Miller
Journal:  Cardiol Clin       Date:  1992-11       Impact factor: 2.213

10.  Role of left ventricular stiffness in heart failure with normal ejection fraction.

Authors:  Dirk Westermann; Mario Kasner; Paul Steendijk; Frank Spillmann; Alexander Riad; Kerstin Weitmann; Wolfgang Hoffmann; Wolfgang Poller; Matthias Pauschinger; Heinz-Peter Schultheiss; Carsten Tschöpe
Journal:  Circulation       Date:  2008-04-14       Impact factor: 29.690

View more
  121 in total

1.  Can Oxygen Transport Analysis Tell Us Why People With Heart Failure With Preserved Ejection Fraction Feel So Poorly?

Authors:  Barry A Borlaug
Journal:  Circulation       Date:  2018-01-09       Impact factor: 29.690

2.  Skeletal Muscle Compensation for Cardiac Muscle Insufficiency in Heart Failure and Reduced Ejection Fraction.

Authors:  Yogesh N V Reddy; Masaru Obokata; Mark J Haykowsky; Barry A Borlaug
Journal:  Circ Heart Fail       Date:  2018-01       Impact factor: 8.790

3.  Myocardial Energetics in Heart Failure With Preserved Ejection Fraction.

Authors:  Omar F AbouEzzeddine; Bradley J Kemp; Barry A Borlaug; Brian P Mullan; Atta Behfar; Sorin V Pislaru; Marat Fudim; Margaret M Redfield; Panithaya Chareonthaitawee
Journal:  Circ Heart Fail       Date:  2019-10-15       Impact factor: 8.790

Review 4.  Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.

Authors:  Sanjiv J Shah; Dalane W Kitzman; Barry A Borlaug; Loek van Heerebeek; Michael R Zile; David A Kass; Walter J Paulus
Journal:  Circulation       Date:  2016-07-05       Impact factor: 29.690

Review 5.  Towards Precision in HF Pharmacotherapy.

Authors:  Nicholas B Norgard; Carolyn Hempel
Journal:  Curr Heart Fail Rep       Date:  2017-02

Review 6.  Preventing heart failure: the role of physical activity.

Authors:  Matthew Nayor; Ramachandran S Vasan
Journal:  Curr Opin Cardiol       Date:  2015-09       Impact factor: 2.161

7.  Mechanisms of Chronotropic Incompetence in Heart Failure With Preserved Ejection Fraction.

Authors:  Satyam Sarma; Douglas Stoller; Joseph Hendrix; Erin Howden; Justin Lawley; Sheryl Livingston; Beverley Adams-Huet; Courtney Holmes; David S Goldstein; Benjamin D Levine
Journal:  Circ Heart Fail       Date:  2020-03-13       Impact factor: 8.790

8.  Vitamin D Status and Exercise Capacity in Older Patients with Heart Failure with Preserved Ejection Fraction.

Authors:  Ambarish Pandey; Dalane W Kitzman; Denise K Houston; Haiying Chen; M Kyla Shea
Journal:  Am J Med       Date:  2018-08-01       Impact factor: 4.965

Review 9.  Determinants of exercise intolerance in patients with heart failure and reduced or preserved ejection fraction.

Authors:  Mark J Haykowsky; Corey R Tomczak; Jessica M Scott; D Ian Paterson; Dalane W Kitzman
Journal:  J Appl Physiol (1985)       Date:  2015-04-24

10.  IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction.

Authors:  Benjamin W Van Tassell; Cory R Trankle; Justin M Canada; Salvatore Carbone; Leo Buckley; Dinesh Kadariya; Marco G Del Buono; Hayley Billingsley; George Wohlford; Michele Viscusi; Claudia Oddi-Erdle; Nayef A Abouzaki; Dave Dixon; Giuseppe Biondi-Zoccai; Ross Arena; Antonio Abbate
Journal:  Circ Heart Fail       Date:  2018-08       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.